Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice

Synergistic Effects of Antidementia Drugs on Spatial Learning and Recall in the APP23 Transgenic Mouse Model of Alzheimer's Disease

(2018) Katharina L. Neumeister et al.   JOURNAL OF ALZHEIMERS DISEASE

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

(2017) Philippe De Deurwaerdère et al.   PROGRESS IN NEUROBIOLOGY

Olfactory Deficits and Amyloid-β Burden in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Aging: A PiB PET Study

(2017) Alex Bahar-Fuchs et al.   JOURNAL OF ALZHEIMERS DISEASE

Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation

(2015) Yasushi Yabuki et al.   BRAIN RESEARCH

The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease

(2015) Naoyuki Sato et al.   Frontiers in Aging Neuroscience

Stimulation of Sigma-1 Receptor Ameliorates Depressive-like Behaviors in CaMKIV Null Mice

(2014) Shigeki Moriguchi et al.   MOLECULAR NEUROBIOLOGY

Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice

(2014) M.R. Islam et al.   NEUROSCIENCE

Differential Control of Learning and Anxiety along the Dorsoventral Axis of the Dentate Gyrus

(2013) Mazen A. Kheirbek et al.   NEURON

Decreased CaMKII and PKC activities in specific brain regions are associated with cognitive impairment in neonatal ventral hippocampus-lesioned rats

(2013) Y. Yabuki et al.   NEUROSCIENCE

Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice

(2013) Y. Yabuki et al.   NEUROSCIENCE

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease

(2013) Chris G. Parsons et al.   NEUROTOXICITY RESEARCH

The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias

(2012) Gabriele Sani et al.   CNS DRUGS

Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration

(2012) Yuliya Borre et al.   NEUROPHARMACOLOGY

The serotonergic system in ageing and Alzheimer's disease

(2012) José Julio Rodríguez et al.   PROGRESS IN NEUROBIOLOGY

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

(2011) Seong Hye Choi et al.   CURRENT MEDICAL RESEARCH AND OPINION

Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice

(2011) Marina Yamada et al.   JOURNAL OF ETHNOPHARMACOLOGY

Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats

(2011) Jouni Ihalainen et al.   NEUROPHARMACOLOGY

Serotonin signaling is associated with lower amyloid-  levels and plaques in transgenic mice and humans

(2011) J. R. Cirrito et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission

(2011) Abigail M. Polter et al.   Frontiers in Molecular Neuroscience

Combination of memantine and donepezil reverses cognitive deficits in transgenic mice with both amyloid-beta plaques and neurofibrillary tangles

(2010) Frank M. LaFerla et al.   Alzheimers & Dementia

Alternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementia

(2010) Russ S. Muramatsu et al.   American Journal Geriatric Pharmacotherapy

Olfactory Dysfunction Correlates with Amyloid-  Burden in an Alzheimer's Disease Mouse Model

(2010) D. W. Wesson et al.   JOURNAL OF NEUROSCIENCE

A Novel Cognitive Enhancer, ZSET1446/ST101, Promotes Hippocampal Neurogenesis and Ameliorates Depressive Behavior in Olfactory Bulbectomized Mice

(2010) N. Shioda et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice

(2009) Feng Han et al.   BRAIN RESEARCH

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease Not Affected by Co-Administration of Memantine

(2009) Joshua Shua-Haim et al.   CLINICAL DRUG INVESTIGATION

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

(2009) O L Lopez et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pharmacological Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) in Nursing Homes: Development of Practice Recommendations in a Swiss Canton

(2008) Jean-François Locca et al.   Journal of the American Medical Directors Association

Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders

(2008) Nobuyuki Yamasaki et al.   Molecular Brain

Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

(2007) Martin Steinberg et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice

(2007) F. Han et al.   NEUROSCIENCE